De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Hikma Pharmaceuticals Dividend
Dividend criteriumcontroles 5/6
Hikma Pharmaceuticals is een dividendbetalend bedrijf met een huidig rendement van 3.11% dat ruimschoots wordt gedekt door de winst.
Belangrijke informatie
3.1%
Dividendrendement
61%
Uitbetalingsratio
| Gemiddelde opbrengst industrie | 2.3% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | UK£0.790 |
| Winst per aandeel | UK£1.29 |
| Dividendrendementsvoorspelling | 3.4% |
Recente dividendupdates
Recent updates
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 11
Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate
Aug 01Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Het dividend per aandeel van HIK is de afgelopen 10 jaar stabiel gebleven.
Groeiend dividend: De dividendbetalingen van HIK zijn de afgelopen 10 jaar gestegen.
Dividendrendement versus markt
| Hikma Pharmaceuticals Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (HIK) | 3.1% |
| Markt onderkant 25% (GB) | 2.1% |
| Markt Top 25% (GB) | 5.5% |
| Gemiddelde industrie (Pharmaceuticals) | 2.3% |
| Analist prognose (HIK) (tot 3 jaar) | 3.4% |
Opmerkelijk dividend: Het dividend van HIK ( 3.11% ) is hoger dan dat van de onderste 25% van de dividendbetalers op de UK markt ( 2.11% ).
Hoog dividend: Het dividend HIK ( 3.11% ) is laag vergeleken met de top 25% van dividendbetalers in de UK markt ( 5.54% ).
Winstuitkering aan aandeelhouders
Verdiendekking: Met zijn redelijke payout ratio ( 61.2% ) worden de dividendbetalingen van HIK gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Met zijn redelijk lage cash payout ratio ( 46.2% ) worden de dividendbetalingen van HIK goed gedekt door de kasstromen.